http://www.bellerophon.com
Bellerophon Therapeutics, Inc. Company Intro
Bellerophon Therapeutics is a clinical-stage biotherapeutics company. We are focused on developing innovative therapies in the treatment of cardiopulmonary diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. More … Continued
Industry
Healthcare
Bellerophon Therapeutics, Inc. Headquaters
184 Liberty Corner Road
Warren,07059
United States
Bellerophon Therapeutics, Inc. Share price
14 Sep 2022 08:47 GMT
$1.1700
-0.03 (-2.5 %)
Bellerophon Therapeutics, Inc. Market cap
$12.791 M
WMC RANKING
2023
Bellerophon Therapeutics, Inc. # 445
BiotechnologyLatest Bellerophon Therapeutics, Inc. News
29 Mar 2023
Bellerophon Therapeutics (NASDAQ:BLPH) Coverage ...
Bellerophon Therapeutics, Inc is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical...
29 Mar 2023
Bellerophon Therapeutics (NASDAQ:BLPH) Coverage ...
Bellerophon Therapeutics, Inc is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical...
29 Mar 2023
Bellerophon Therapeutics (NASDAQ:BLPH) Coverage ...
Bellerophon Therapeutics, Inc is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical...
WMC Market Score
WMC Market to Revenue Score
Bellerophon Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Bellerophon Therapeutics, Inc. | USD | $0 | $28,025 | $-25,219 | $128M | 445 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Bellerophon Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Bellerophon Therapeutics, Inc. Post vs Top 4 Industry Competitors
Bellerophon Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Bellerophon Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Bellerophon Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Bellerophon Therapeutics, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
